Keebeck Alpha, LP Edwards Lifesciences Corp Transaction History

Keebeck Alpha, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$81.41 - $94.33 $120,079 - $139,136	-1,475 Reduced 24.84%	4,462 $420,000
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $228,052 - $259,530	3,071 Added 107.15%	5,937 $491,000
Q3 2022 Nov 07, 2022	BUY	$82.37 - $107.29 $236,072 - $307,493	2,866 New	2,866 $237,000
Q3 2020 Nov 02, 2020	SELL	$67.19 - $87.44 $232,880 - $303,067	-3,466 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$57.54 - $76.95 $136,484 - $182,525	2,372 Added 216.82%	3,466 $240,000
Q1 2020 May 06, 2020	SELL	$52.41 - $81.0 $14,779 - $22,842	-282 Reduced 20.49%	1,094 $206,000
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $98,659 - $112,955	1,376 New	1,376 $321,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.